A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer
Authors
Keywords
adverse events; febrile neutropenia; dose modification; biliary drainage; risk factor
Journal
Oncotarget
Volume 8, Issue 67, Pages -
Publisher
Impact Journals, LLC
Online
2017-12-01
DOI
10.18632/oncotarget.22795

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.